Abstract
Pharmacological penalization with atropine has been shown to be equally effective as conventional occlusion therapy in the treatment of amblyopia in children. Reverse amblyopia of the sound eye with atropine penalization has been reported before, but is more common in cases where the effect is augmented with optical penalization and is mostly reversible. We report a case of reverse amblyopia with atropine penalization, in a 4-year-old girl, which was refractory to treatment. This report highlights the need for strict monitoring of the vision in the sound eye and regular follow-up in children undergoing amblyopia treatment.
Keywords
Publication details
- DOI
- 10.4103/0974-620x.71897
- Journal
- Oman Journal of Ophthalmology, 3(3), 148-149
- Publisher
- Medknow Publications
- Open access
- Gold open access
Cite this article
APA 7
Patil, P. A., Meenakshi, S., & Surendran, T. S. (2010). Refractory reverse amblyopia with atropine penalization. Oman Journal of Ophthalmology, 3(3), 148-149. https://doi.org/10.4103/0974-620x.71897
MLA 9
Patil, Preeti Ajit, et al. "Refractory reverse amblyopia with atropine penalization." Oman Journal of Ophthalmology, vol. 3, no. 3, 2010, pp. 148-149. https://doi.org/10.4103/0974-620x.71897.
Chicago (author–date)
Patil, Preeti Ajit, S Meenakshi, and T S Surendran. 2010. "Refractory reverse amblyopia with atropine penalization." Oman Journal of Ophthalmology 3 (3): 148-149. https://doi.org/10.4103/0974-620x.71897.
Harvard
Patil, P. A., Meenakshi, S. and Surendran, T. S. (2010) 'Refractory reverse amblyopia with atropine penalization', Oman Journal of Ophthalmology, 3(3), pp. 148-149. doi:10.4103/0974-620x.71897.
Vancouver
Patil PA, Meenakshi S, Surendran TS. Refractory reverse amblyopia with atropine penalization. Oman Journal of Ophthalmology. 2010;3(3):148-149. doi:10.4103/0974-620x.71897
IEEE
P. A. Patil, S. Meenakshi, and T. S. Surendran, "Refractory reverse amblyopia with atropine penalization," Oman Journal of Ophthalmology, vol. 3, no. 3, pp. 148-149, 2010, doi: 10.4103/0974-620x.71897.